Fort Washington Investment Advisors Inc. OH raised its holdings in shares of The Ensign Group, Inc. (NASDAQ:ENSG - Free Report) by 40.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 195,540 shares of the company's stock after acquiring an additional 56,023 shares during the period. Fort Washington Investment Advisors Inc. OH owned approximately 0.34% of The Ensign Group worth $33,633,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. Cedar Mountain Advisors LLC bought a new position in shares of The Ensign Group in the 1st quarter worth $32,000. Transamerica Financial Advisors LLC acquired a new stake in shares of The Ensign Group during the second quarter worth $26,000. Monetary Solutions Ltd bought a new stake in The Ensign Group in the fourth quarter valued at about $30,000. Bayban bought a new stake in The Ensign Group in the fourth quarter valued at about $31,000. Finally, Caitlin John LLC bought a new stake in The Ensign Group in the second quarter valued at about $31,000. Institutional investors and hedge funds own 96.12% of the company's stock.
Insider Buying and Selling
In related news, Director John Agwunobi sold 392 shares of the firm's stock in a transaction on Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the sale, the director owned 9,503 shares of the company's stock, valued at approximately $1,625,583.18. This trade represents a 3.96% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 4.00% of the company's stock.
Key Stories Impacting The Ensign Group
Here are the key news stories impacting The Ensign Group this week:
- Positive Sentiment: No new deterioration in Ensign’s operating results was reported in these articles. The company’s most recently provided financial backdrop remains supportive, including quarterly earnings that exceeded analyst expectations and double-digit year-over-year revenue growth.
- Neutral Sentiment: Multiple law firms—including Rosen, Kaplan Fox, Robbins Geller, and others—are seeking investors who may serve as lead plaintiff. Investors covered by the alleged class period, February 10, 2022 through June 18, 2026, generally have until December 7, 2026 to apply. Rosen class action announcement
- Negative Sentiment: The repeated notices confirm that a securities class action is pending against The Ensign Group and certain officers on behalf of investors who allege losses. The litigation could result in legal expenses, settlement costs, management distraction, and continued volatility; however, the articles provide allegations rather than a judgment or quantified financial liability. Bronstein Gewirtz Grossman lawsuit announcement
Wall Street Analyst Weigh In
Several equities analysts have weighed in on ENSG shares. Wall Street Zen raised The Ensign Group from a "hold" rating to a "buy" rating in a research note on Saturday, October 3rd. Weiss Ratings upgraded The Ensign Group from a "buy (b-)" rating to a "buy (b)" rating in a report on Thursday, October 8th. Truist Financial boosted their target price on The Ensign Group from $202.00 to $207.00 and gave the stock a "hold" rating in a research report on Thursday, July 30th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $228.00 price target on shares of The Ensign Group in a research note on Tuesday, July 28th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $216.25.
View Our Latest Stock Analysis on The Ensign Group
The Ensign Group Trading Up 1.3%
ENSG opened at $178.11 on Friday. The firm's fifty day moving average is $175.55 and its two-hundred day moving average is $175.58. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21. The firm has a market cap of $10.38 billion, a PE ratio of 27.92, a price-to-earnings-growth ratio of 1.67 and a beta of 0.66. The Ensign Group, Inc. has a twelve month low of $141.58 and a twelve month high of $218.00.
The Ensign Group (NASDAQ:ENSG - Get Free Report) last announced its quarterly earnings results on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, topping analysts' consensus estimates of $1.80 by $0.12. The company had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.44 billion. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The business's quarterly revenue was up 16.7% compared to the same quarter last year. During the same period last year, the firm posted $1.59 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Equities research analysts anticipate that The Ensign Group, Inc. will post 7.04 EPS for the current year.
The Ensign Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, October 31st. Investors of record on Wednesday, September 30th will be given a $0.0650 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.1%. The Ensign Group's dividend payout ratio is currently 4.08%.
The Ensign Group Company Profile
(
Free Report)
The Ensign Group, Inc NASDAQ: ENSG is a healthcare services company that operates through a network of skilled nursing, rehabilitation and senior living facilities. Its centers provide post-acute care, including nursing services, physical, occupational and speech therapy, short-term rehabilitation, and long-term residential care for older adults and patients recovering from illness, injury or surgery.
The company also provides home health and hospice services, as well as a range of ancillary services supporting post-acute care.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Ensign Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Ensign Group wasn't on the list.
While The Ensign Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.